Skip to content
10-Q

Quarterly Report

Pyxis Oncology, Inc. PYXS

0001193125-25-261696

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 62.26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 62.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 61.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.72M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.51M sh
Capex Q3 2025 · Sep 30, 2025 $9K
Capex Q3 2025 · Sep 30, 2024 $237K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$53.08M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$38.38M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $8.92M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $19.47M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $12.06M
Stockholders Equity Q3 2025 · Sep 30, 2025 $68.78M
Stockholders Equity Q3 2025 · Jun 30, 2025 $87.64M
Stockholders Equity Q3 2025 · Dec 31, 2024 $120.75M
Stockholders Equity Q3 2025 · Sep 30, 2024 $153.68M
Stockholders Equity Q3 2025 · Jun 30, 2024 $169.79M
Stockholders Equity Q3 2025 · Dec 31, 2023 $125.7M
Current Liabilities Q3 2025 · Sep 30, 2025 $19.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $17.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $36.83M
Total Liabilities Q3 2025 · Dec 31, 2024 $36.43M
Current Assets Q3 2025 · Sep 30, 2025 $83.07M
Current Assets Q3 2025 · Dec 31, 2024 $132.44M
Total Assets Q3 2025 · Sep 30, 2025 $105.6M
Total Assets Q3 2025 · Dec 31, 2024 $157.18M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.99
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.73
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.99
Eps Basic Q3 2025 · Sep 30, 2024 −$0.35
Eps Basic Q3 2025 · Sep 30, 2024 −$0.73
Sga Expense Q3 2025 · Sep 30, 2025 $5.65M
Sga Expense Q3 2025 · Sep 30, 2025 $16.96M
Sga Expense Q3 2025 · Sep 30, 2024 $6.01M
Sga Expense Q3 2025 · Sep 30, 2024 $20.34M
Rd Expense Q3 2025 · Sep 30, 2025 $17.81M
Rd Expense Q3 2025 · Sep 30, 2025 $51.99M
Rd Expense Q3 2025 · Sep 30, 2024 $17.74M
Rd Expense Q3 2025 · Sep 30, 2024 $44.72M
Net Income Q3 2025 · Sep 30, 2025 −$22M
Net Income Q3 2025 · Sep 30, 2025 −$61.52M
Net Income Q3 2025 · Sep 30, 2024 −$21.2M
Net Income Q3 2025 · Sep 30, 2024 −$41.76M
Operating Income Q3 2025 · Sep 30, 2025 −$23.46M
Operating Income Q3 2025 · Sep 30, 2025 −$66.13M
Operating Income Q3 2025 · Sep 30, 2024 −$23.75M
Operating Income Q3 2025 · Sep 30, 2024 −$49.39M
Revenue Q3 2025 · Sep 30, 2025 $2.82M
Revenue Q3 2025 · Sep 30, 2024 $16.15M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $475K